US BioUpton Int. Revenue and Competitors
Estimated Revenue & Valuation
- US BioUpton Int.'s estimated annual revenue is currently $775k per year.
- US BioUpton Int.'s estimated revenue per employee is $155,000
Employee Data
- US BioUpton Int. has 5 Employees.
- US BioUpton Int. grew their employee count by 0% last year.
US BioUpton Int.'s People
Name | Title | Email/Phone |
---|
US BioUpton Int. Competitors & AlternativesAdd Company
Competitor Name | Revenue | Number of Employees | Employee Growth | Total Funding | Valuation |
---|---|---|---|---|---|
#1 | $79.1M | 510 | 0% | N/A | N/A |
#2 | $0.9M | 6 | 20% | N/A | N/A |
#3 | $1.9M | 12 | 9% | N/A | N/A |
#4 | $5.4M | 35 | 21% | N/A | N/A |
#5 | $0.8M | 5 | -29% | N/A | N/A |
#6 | $8.7M | 56 | 24% | N/A | N/A |
#7 | $1.4M | 9 | -31% | N/A | N/A |
#8 | $1.1M | 7 | 0% | N/A | N/A |
#9 | $36M | 232 | 19% | N/A | N/A |
#10 | $15.5M | 100 | -2% | N/A | N/A |
What Is US BioUpton Int.?
Tissue microarray from BioUpton includes normal, malignant or metastatic formats, which can be used to validate the clinical relevance of potential biological targets in diagnostics, therapeutics and study new protein markers and genes. BioUpton provides integrated product and service for Antibody production and validation. There are broad selections of tissue sections and tissue arrays from vast normal or disease tissues for antibody validation using our immuno-kit. In addition, we may offer either polyclonal antibody or monoclonal antibody service including antibody design, production, purification, and validation. BioUpton also provides custom tissue array blocks and sections, as well as services of immunohistochemistry (IHC) staining and In situ hybridization (ISH) on tissue arrays.
keywords:N/AN/A
Total Funding
5
Number of Employees
$775k
Revenue (est)
0%
Employee Growth %
N/A
Valuation
N/A
Accelerator
Company Name | Revenue | Number of Employees | Employee Growth | Total Funding |
---|---|---|---|---|
#1 | $1M | 12 | 0% | N/A |
#2 | $3.7M | 29 | 4% | N/A |